Alert: Major Price Advance (11/27/23)-Abeona Therapeutics Inc (NASDAQ: ABEO).


On 11/27/23, Abeona Therapeutics Inc (NASDAQ: ABEO) stock enjoyed a major increase of 11.6%, closing at $4.81. The stock has been exceptionally strong relative to the market over the last nine months and has risen 14.0% during the last week.


Current PriceTarget Research Rating

ABEO is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.

Abeona Therapeutics has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Abeona Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 93, resulting in the Low Neutral Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.